369 / 1266
Conclusions
• Systemic therapies can improve outcome in brain tumor
patients
• Blood brain barrier can be a limiting factor
• Insufficient understanding of tumor biology as one
limiting factor
• Emerging targeted agents with putative activity in brain
tumors
• Predictive factors may help to tailor systemic therapies
• Need for more research